GlassScriptPhysician profile
Jody L Long
NPI 1558639294
$5,997.51
in general payments reported to CMS, 2019-2025
20 companies · $670 in 2025
The $670 reported for 2025 was more than what 80% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,550 · 2023: $1,434 · 2024: $2,343 · 2025: $670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,262 · Travel and Lodging: $1,112 · Education: $73.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,261.99 |
| Travel and Lodging | $1,111.71 |
| Education | $73.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,702.84 | 2022-2024 | Watchman Flx, Watchman Access System, Rhythmia Mapping System |
| Shockwave Medical, INC | $432.93 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Medtronic, INC. | $299.43 | 2023-2025 | Onyx Frontier, Symplicity G3, Ffrangio |
| Cvrx, INC. | $226.83 | 2023 | Barostim Neo System |
| Novo Nordisk INC | $213.07 | 2024 | Wegovy |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $181.17 | 2024-2025 | Lifevest |
| Impulse Dynamics (USA) INC. | $176.73 | 2023 | Optimizer |
| Abbott Laboratories | $148.34 | 2022-2025 | Cardiomems, Mitraclip |
| Astrazeneca Pharmaceuticals LP | $123.12 | 2023 | Farxiga |
| Heartflow, INC. | $121.11 | 2024 | |
| Astellas Pharma US INC | $73.99 | 2023 | |
| Edwards Lifesciences Corporation | $72.98 | 2023-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Kiniksa Pharmaceuticals, LTD. | $49.31 | 2022-2023 | Arcalyst |
| Boehringer Ingelheim Pharmaceuticals, INC. | $42.43 | 2022 | |
| Pfizer INC. | $36.62 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cleerly, INC. | $21.49 | 2025 | Cleerly Ischemia, Cleerly Labs |
| Abiomed | $20.32 | 2024 | Impella |
| Ethicon US, LLC | $19.71 | 2022 | |
| Alnylam Pharmaceuticals INC. | $18.34 | 2023 | Onpattro |
| Philips North America LLC | $16.75 | 2025 | Coronary Other |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jody Long listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.